Physician

Bharat Jenigiri, MD

According to 2025 Medicare claims, Bharat Jenigiri, MD (NPI: 1912053364) practices medical oncology in the Cedar Rapids, IA market, with the plurality of this provider's patient population coming from Linn, IA. This provider's primary affiliated billing organization is PHYSICIANS' CLINIC OF IOWA, PC (NPI: 1821075599; TIN: 421462899) and primary practice location at 52403-2414. Jenigiri is affiliated with the UnityPoint Accountable Care, L.C. (ACO ID: A5170), Aledade 155 National MSSP (ACO ID: A5358), and Main Street Rural Health Willow ACO LLC (ACO ID: A5404), participating under the MSSP model.

Jenigiri's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 586 traditional Medicare patients, billed 176,323 HCPCS/CPT codes, and received $3,708,154 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,084 prescription claims across 185 beneficiaries totaling $2,355,181 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 30 claims. Open Payments data shows 65 records totaling $6,503. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,394,334 to $3,708,154. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $466,509 to $2,355,181. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,194 and ending at $1,559.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	412	95,810	$1,394,334
2016	458	154,403	$2,229,146
2017	523	161,404	$2,161,628
2018	552	150,873	$2,786,438
2019	533	179,667	$3,476,926
2020	544	215,790	$3,509,460
2021	505	285,223	$4,680,338
2022	512	211,991	$3,729,226
2023	543	172,686	$3,175,182
2024	586	176,323	$3,708,154

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	127	490	$466,509
2016	147	849	$892,093
2017	142	802	$1,042,452
2018	160	901	$826,586
2019	151	895	$1,312,399
2020	155	827	$1,734,212
2021	155	1,036	$3,358,848
2022	176	949	$2,993,680
2023	159	865	$2,132,397
2024	185	1,084	$2,355,181

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$207
2016	N/R	104	$27,584
2017	N/R	66	$10,677
2018	N/R	56	$10,538
2019	N/R	35	$3,093
2020	N/R	N/R	N/R
2021	N/R	26	$3,260
2022	N/R	16	$168
2023	N/R	24	$1,494
2024	N/R	30	$681

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	336	875	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	221	275	$62
80053	Blood test, comprehensive group of blood chemicals	461	1,585	$10
36415	Insertion of needle into vein for collection of blood sample	423	1,051	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	459	1,644	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	19	532	$313,525
Erleada	Apalutamide	20	600	$285,196
Promacta	Eltrombopag Olamine	12	360	$223,780
Xtandi	Enzalutamide	21	630	$210,690
Venclexta	Venetoclax	25	716	$204,105

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8999	Prescription drug, oral, chemotherapeutic, nos	N	N/R	14	$493
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	16	$188

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	47	$981	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	18	$5,522	PFIZER INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bharat Jenigiri, MD?

Tedicare shows public-source Medicare data for Bharat Jenigiri, MD (NPI 1912053364), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bharat Jenigiri, MD have ACO affiliation data?

Bharat Jenigiri, MD is shown with ACO affiliation data for UnityPoint Accountable Care, L.C. (MSSP, ACO ID A5170), Aledade 155 National MSSP (MSSP, ACO ID A5358), and Main Street Rural Health Willow ACO LLC (MSSP, ACO ID A5404).

What billing organization is linked to Bharat Jenigiri, MD?

Bharat Jenigiri, MD is linked to PHYSICIANS' CLINIC OF IOWA, PC (billing NPI 1821075599) in the available physician profile data.

Does Bharat Jenigiri, MD have Open Payments data?

Bharat Jenigiri, MD has 65 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.